Monte M. Winslow
Affiliations: | Stanford University, Palo Alto, CA |
Area:
GeneticsGoogle:
"Monte Winslow"Mean distance: 17.58
Parents
Sign in to add mentorGerald Crabtree | grad student | 2006 | Stanford | |
(Calcineurin/NFAT signaling controls B lymphocyte responses and regulates bone mass.) |
Children
Sign in to add traineeChristopher D. McFarland | post-doc | 2014-2018 | Stanford (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Blair LM, Juan JM, Sebastian L, et al. (2023) Oncogenic context shapes the fitness landscape of tumor suppression. Nature Communications. 14: 6422 |
Yousefi M, Andrejka L, Szamecz M, et al. (2023) Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. 120: e2303224120 |
Gonzalez MA, Lu DR, Yousefi M, et al. (2023) Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages. The Journal of Experimental Medicine. 220 |
Yousefi M, Andrejka L, Winslow MM, et al. (2023) Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma. Biorxiv : the Preprint Server For Biology |
Lee MC, Cai H, Murray CW, et al. (2023) A multiplexed in vivo approach to identify driver genes in small cell lung cancer. Cell Reports. 42: 111990 |
Tang R, Shuldiner EG, Kelly M, et al. (2023) Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth. Nature Cell Biology |
Yousefi M, Boross G, Weiss C, et al. (2022) Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities. Cancer Research. 82: 1589-1602 |
Foggetti G, Li C, Cai H, et al. (2022) Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment. Molecular & Cellular Oncology. 9: 1994328 |
Murray CW, Brady JJ, Han M, et al. (2022) LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer. Nature Communications. 13: 1090 |
Dorsch M, Kowalczyk M, Planque M, et al. (2021) Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis. Cell Reports. 37: 110056 |